Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer

• Published in: Oncogenesis (New York, NY) Vol. 7; no. 5; pp. 44 - 12
• Main Authors: Tse, Aki Pui-Wah, Sze, Karen Man-Fong, Shea, Queenie Tsung-Kwan, Chiu, Elley Yung-Tuen, Tsang, Felice Ho-Ching, Chiu, David Kung-Chun, Zhang, Misty Shuo, Lee, Derek, Xu, Iris Ming-Jing, Chan, Cerise Yuen-Ki, Koh, Hui-Yu, Wong, Chun-Ming, Zheng, Yong-Ping, Ng, Irene Oi-Lin, Wong, Carmen Chak-Lui
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 25.05.2018; Nature Publishing Group
• Subjects: 101/28; 13; 13/106; 13/51; 13/89; 38/1; 631/67/1504/1610; 631/67/327; 82/29; 82/80; Apoptosis; Cell Biology; Chronic infection; Collagen; Extracellular matrix; Gene expression; Hepatitis; Hepatitis B; Hepatocellular carcinoma; Hepatocytes; Human Genetics; Hypoxia; Hypoxia-inducible factors; Internal Medicine; Liver cancer; Lysyl oxidase; Malignancy; Medicine; Medicine & Public Health; Metastases; Metastasis; Oncology; Perfusion; Protein X; Proteins; Scanning electron microscopy; Tumorigenesis
• ISSN: 2157-9024; 2157-9024
• DOI: 10.1038/s41389-018-0052-8

Hepatocellular carcinoma (HCC), accounting for 90% of primary liver cancer, is a lethal malignancy that is tightly associated with chronic hepatitis B virus (HBV) infection. HBV encodes a viral onco-protein, transactivator protein X (HBx), which interacts with proteins of hepatocytes to promote oncogenesis. Our current study focused on the interaction of HBx with a transcription factor, hypoxia-inducible factor-1α (HIF-1α), which is stabilized by low O 2 condition (hypoxia) and is found to be frequently overexpressed in HCC intra-tumorally due to poor blood perfusion. Here, we showed that overexpression of HBx by tetracycline-inducible systems further stabilized HIF-1α under hypoxia in HBV-negative HCC cell lines. Reversely, knockdown of HBx reduced HIF-1α protein stabilization under hypoxia in HBV-positive HCC cell lines. More intriguingly, overexpression of HBx elevated the mRNA and protein expression of a family of HIF-1α target genes, the lysyl oxidase (LOX) family in HCC. The LOX family members function to cross-link collagen in the extracellular matrix (ECM) to promote cancer progression and metastasis. By analyzing the collagens under scanning electron microscope, we found that collagen fibers were significantly smaller in size when incubated with conditioned medium from HBx knockdown HCC cells as compared to control HCC cells in vitro. Transwell invasion assay further revealed that less cells were able to invade through the matrigel which was pre-treated with conditioned medium from HBx knockdown HCC cells as compared to control HCC cells. Orthotopic and subcutaneous HCC models further showed that knockdown of HBx in HCC cells reduced collagen crosslinking and stiffness in vivo and repressed HCC growth and metastasis. Taken together, our in vitro and in vivo studies showed the HBx remodeled the ECM through HIF-1α/LOX pathway to promote HCC metastasis.